ArticleVeterinary research communications2026
Development and validation of an E2 based indirect ELISA for serological detection of porcine Getah virus.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Getah virus (GETV) is an emerging mosquito borne alphavirus that has recently expanded in Chinese swine herds and causes reproductive losses and reduced growth in pigs. The absence of a standardized high throughput serological assay has limited surveillance and hindered accurate assessment of GETV circulation. In this study, we developed and validated an indirect ELISA based on recombinant full length E2 protein for detection of anti-GETV IgG in swine serum. The E2 gene from a circulating strain was expressed in Escherichia coli as inclusion bodies, followed by denaturation, redox refolding, and purification to > 90% purity. Positive and negative control sera were defined by virus neutralization. Systematic optimization identified 1 μg/mL antigen coating and 1:100 serum dilution as optimal, and the cutoff was set at OD
Indexed as
Identifiers
42455209What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.